Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
Phosphodiesterase Inhibitors for Pulmonary Hypertension
Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells
Chapter 6. Phosphodiesterase 5 inhibitors
Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
